Stay updated on Modakafusp Alfa in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Modakafusp Alfa in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Modakafusp Alfa in Multiple Myeloma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-14T02:11:00.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a modification in the dose of modakafusp alfa being tested in a study on adult participants with relapsed/refractory multiple myeloma. This change may impact the assessment of the clinical activity and safety profile of the treatment regimen.
    Difference
    0.1%
    Check dated 2024-06-06T16:04:59.000Z thumbnail image
  7. Check
    16 days ago
    Change Detected
    Summary
    The value (Estimated) on the webpage has recently changed to . This change represents an update in the estimated study completion date for the clinical trial involving Modakafusp Alfa on adult participants with relapsed/refractory multiple myeloma.
    Difference
    0.0%
    Check dated 2024-05-31T02:18:09.000Z thumbnail image
  8. Check
    17 days ago
    Change Detected
    Summary
    The value on the webpage has changed from an estimated completion date of December 22, 2023, to an actual completion date of May 29, 2024. This change indicates that the study's completion date has been updated to a later time frame, possibly affecting the availability of results or further progress in the medical and healthcare-related research.
    Difference
    1%
    Check dated 2024-05-30T01:39:57.000Z thumbnail image
  9. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying the health conditions and prior treatments required for inclusion in the study. This change provides more specific information about the requirements for participants, including criteria for disease progression and previous therapies.
    Difference
    21%
    Check dated 2024-05-22T12:44:24.000Z thumbnail image
  10. Check
    46 days ago
    Change Detected
    Summary
    The value 'Go to the classic website' has been updated to 'Site Map' on the webpage. This change likely indicates a shift in the type of intervention related to medical and healthcare publications and documentation.
    Difference
    0.6%
    Check dated 2024-05-01T17:37:04.000Z thumbnail image

Stay in the know with updates to Modakafusp Alfa in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Modakafusp Alfa in Multiple Myeloma Clinical Trial page.